{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:46Z","timestamp":1707524626728},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,8]]},"DOI":"10.7759\/cureus.27790","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T21:10:02Z","timestamp":1659993002000},"source":"Crossref","is-referenced-by-count":1,"title":["Prenatal Buprenorphine\/Naloxone or Methadone Use on Neonatal Outcomes in Michigan"],"prefix":"10.7759","author":[{"given":"Gregory","family":"Goshgarian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Muterspaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Zikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhakar","family":"Ezhuthachan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaur-Dong","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neli","family":"Ragina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2019.01.001","article-title":"The United States opioid epidemic","volume":"43","author":"Lyden J","year":"2019","unstructured":"Lyden J, Binswanger IA. The United States opioid epidemic. Semin Perinatol. 2019, 43:123-31. 10.1053\/j.semperi.2019.01.001","journal-title":"Semin Perinatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3801","article-title":"Public health surveillance of prenatal opioid exposure in mothers and infants","volume":"143","author":"Honein MA","year":"2019","unstructured":"Honein MA, Boyle C, Redfield RR. Public health surveillance of prenatal opioid exposure in mothers and infants. Pediatrics. 2019, 143:e20183801. 10.1542\/peds.2018-3801","journal-title":"Pediatrics"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai AH","year":"2021","unstructured":"Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017. JAMA. 2021, 325:146-55. 10.1001\/jama.2020.24991","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes","volume":"121","author":"Maeda A","year":"2014","unstructured":"Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology. 2014, 121:1158-65. 10.1097\/ALN.0000000000000472","journal-title":"Anesthesiology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1556740","article-title":"Prescription opioids in pregnancy and birth outcomes: a review of the literature","volume":"4","author":"Yazdy MM","year":"2015","unstructured":"Yazdy MM, Desai RJ, Brogly SB. Prescription opioids in pregnancy and birth outcomes: a review of the literature. J Pediatr Genet. 2015, 4:56-70. 10.1055\/s-0035-1556740","journal-title":"J Pediatr Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-4131","article-title":"Maternal use of opioids during pregnancy and congenital malformations: a systematic review","volume":"139","author":"Lind JN","year":"2017","unstructured":"Lind JN, Interrante JD, Ailes EC, et al.. Maternal use of opioids during pregnancy and congenital malformations: a systematic review. Pediatrics. 2017, 139:e20164131. 10.1542\/peds.2016-4131","journal-title":"Pediatrics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-029074","article-title":"Neonatal opioid withdrawal syndrome","volume":"146","author":"Patrick SW","year":"2020","unstructured":"Patrick SW, Barfield WD, Poindexter BB. Neonatal opioid withdrawal syndrome. Pediatrics. 2020, 146:e2020029074. 10.1542\/peds.2020-029074","journal-title":"Pediatrics"},{"key":"ref8","unstructured":"Healthcare Cost and Utilization Project (HCUP). (2021). Accessed. May 25, 2022: http:\/\/www.hcup-us.ahrq.gov\/db\/publishing.jsp."},{"key":"ref9","unstructured":"Treatment for opioid use disorder before, during, and after pregnancy. (2022). Accessed. May 25, 2022: https:\/\/www.cdc.gov\/pregnancy\/opioids\/treatment.html."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1694729","article-title":"Association of maternal buprenorphine or methadone dose with fetal growth indices and neonatal abstinence syndrome","volume":"38","author":"Coulson CC","year":"2021","unstructured":"Coulson CC, Lorencz E, Rittenhouse K, Ramage M, Lorenz K, Galvin SL. Association of maternal buprenorphine or methadone dose with fetal growth indices and neonatal abstinence syndrome. Am J Perinatol. 2021, 38:28-36. 10.1055\/s-0039-1694729","journal-title":"Am J Perinatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.12443","article-title":"The role of preterm birth in the association between opioid maintenance therapy and neonatal abstinence syndrome","volume":"32","author":"Lemon LS","year":"2018","unstructured":"Lemon LS, Naimi A, Caritis SN, Platt RW, Venkataramanan R, Bodnar LM. The role of preterm birth in the association between opioid maintenance therapy and neonatal abstinence syndrome. Paediatr Perinat Epidemiol. 2018, 32:213-22. 10.1111\/ppe.12443","journal-title":"Paediatr Perinat Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000780","article-title":"Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome","volume":"29","author":"Lemon LS","year":"2018","unstructured":"Lemon LS, Caritis SN, Venkataramanan R, Platt RW, Bodnar LM. Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome. Epidemiology. 2018, 29:261-8. 10.1097\/EDE.0000000000000780","journal-title":"Epidemiology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016648367","article-title":"Buprenorphine versus methadone for opioid dependence in pregnancy","volume":"50","author":"Noormohammadi A","year":"2016","unstructured":"Noormohammadi A, Forinash A, Yancey A, Crannage E, Campbell K, Shyken J. Buprenorphine versus methadone for opioid dependence in pregnancy. Ann Pharmacother. 2016, 50:666-72. 10.1177\/1060028016648367","journal-title":"Ann Pharmacother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4137\/SART.S38887","article-title":"A Swedish population-based study of adverse birth outcomes among pregnant women treated with buprenorphine or methadone: preliminary findings","volume":"10","author":"Wurst KE","year":"2016","unstructured":"Wurst KE, Zedler BK, Joyce AR, Sasinowski M, Murrelle EL. A Swedish population-based study of adverse birth outcomes among pregnant women treated with buprenorphine or methadone: preliminary findings. Subst Abuse. 2016, 10:89-97. 10.4137\/SART.S38887","journal-title":"Subst Abuse"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxy091","article-title":"Differences in hospital length of stay between neonates exposed to buprenorphine versus methadone in utero: a retrospective chart review","volume":"24","author":"Fernandez S","year":"2019","unstructured":"Fernandez S, Bruni T, Bishop L, Turuba R, Olibris B, Jumah NA. Differences in hospital length of stay between neonates exposed to buprenorphine versus methadone in utero: a retrospective chart review. Paediatr Child Health. 2019, 24:e104-10. 10.1093\/pch\/pxy091","journal-title":"Paediatr Child Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.07.001","article-title":"Neonatal outcomes following in utero exposure to methadone or buprenorphine: a national cohort study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009","volume":"127","author":"Welle-Strand GK","year":"2013","unstructured":"Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjark\u00f8 L, Ravndal E. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a national cohort study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009. Drug Alcohol Depend. 2013, 127:200-6. 10.1016\/j.drugalcdep.2012.07.001","journal-title":"Drug Alcohol Depend"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2017.157","article-title":"Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome","volume":"38","author":"Tolia VN","year":"2018","unstructured":"Tolia VN, Murthy K, Bennett MM, Miller ES, Benjamin DK, Smith PB, Clark RH. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome. J Perinatol. 2018, 38:75-9. 10.1038\/jp.2017.157","journal-title":"J Perinatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2012.12005.x","article-title":"Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data","volume":"22","author":"Debelak K","year":"2013","unstructured":"Debelak K, Morrone WR, O'Grady KE, Jones HE. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict. 2013, 22:252-4. 10.1111\/j.1521-0391.2012.12005.x","journal-title":"Am J Addict"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000562","article-title":"Buprenorphine and naloxone versus buprenorphine for opioid use disorder in pregnancy: a cohort study","volume":"14","author":"Mullins N","year":"2020","unstructured":"Mullins N, Galvin SL, Ramage M, Gannon M, Lorenz K, Sager B, Coulson CC. Buprenorphine and naloxone versus buprenorphine for opioid use disorder in pregnancy: a cohort study. J Addict Med. 2020, 14:185-92. 10.1097\/ADM.0000000000000562","journal-title":"J Addict Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion no. 711: opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","unstructured":"Committee opinion no. 711. opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017, 130:e81-94. 10.1097\/AOG.0000000000002235","journal-title":"Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau J","year":"2018","unstructured":"Bruneau J, Ahamad K, Goyer M\u00c8, et al.. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018, 190:E247-57. 10.1503\/cmaj.170958","journal-title":"CMAJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12687","article-title":"Treating women with opioid use disorder during pregnancy in Appalachia: initial neonatal outcomes following buprenorphine\u2009+\u2009naloxone exposure","volume":"27","author":"Nguyen L","year":"2018","unstructured":"Nguyen L, Lander LR, O'Grady KE, Marshalek PJ, Schmidt A, Kelly AK, Jones HE. Treating women with opioid use disorder during pregnancy in Appalachia: initial neonatal outcomes following buprenorphine\u2009+\u2009naloxone exposure. Am J Addict. 2018, 27:92-6. 10.1111\/ajad.12687","journal-title":"Am J Addict"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04039.x","article-title":"Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates","volume":"107 Suppl 1","author":"Gaalema DE","year":"2012","unstructured":"Gaalema DE, Scott TL, Heil SH, et al.. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Addiction. 2012, 107 Suppl 1:53-62. 10.1111\/j.1360-0443.2012.04039.x","journal-title":"Addiction"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000640","article-title":"Buprenorphine and naloxone compared with methadone treatment in pregnancy","volume":"125","author":"Wiegand SL","year":"2015","unstructured":"Wiegand SL, Stringer EM, Stuebe AM, Jones H, Seashore C, Thorp J. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol. 2015, 125:363-8. 10.1097\/AOG.0000000000000640","journal-title":"Obstet Gynecol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/2050312114530282","article-title":"Neonatal outcomes following in utero exposure to buprenorphine\/naloxone or methadone","volume":"2","author":"Gawronski KM","year":"2014","unstructured":"Gawronski KM, Prasad MR, Backes CR, Lehman KJ, Gardner DK, Cordero L. Neonatal outcomes following in utero exposure to buprenorphine\/naloxone or methadone. SAGE Open Med. 2014, 2:2050312114530282. 10.1177\/2050312114530282","journal-title":"SAGE Open Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04040.x","article-title":"Neonatal neurobehavior effects following buprenorphine versus methadone exposure","volume":"107 Suppl 1","author":"Coyle MG","year":"2012","unstructured":"Coyle MG, Salisbury AL, Lester BM, Jones HE, Lin H, Graf-Rohrmeister K, Fischer G. Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction. 2012, 107 Suppl 1:63-73. 10.1111\/j.1360-0443.2012.04040.x","journal-title":"Addiction"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-050279","article-title":"Opioid use disorder and perinatal outcomes","volume":"148","author":"Piske M","year":"2021","unstructured":"Piske M, Homayra F, Min JE, et al.. Opioid use disorder and perinatal outcomes. Pediatrics. 2021, 148:e2021050279. 10.1542\/peds.2021-050279","journal-title":"Pediatrics"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.4791","article-title":"Neonatal abstinence syndrome incidence and health care costs in the United States, 2016","volume":"174","author":"Strahan AE","year":"2020","unstructured":"Strahan AE, Guy GP Jr, Bohm M, Frey M, Ko JY. Neonatal abstinence syndrome incidence and health care costs in the United States, 2016. JAMA Pediatr. 2020, 174:200-2. 10.1001\/jamapediatrics.2019.4791","journal-title":"JAMA Pediatr"},{"key":"ref29","article-title":"The opioid-exposed newborn: assessment and pharmacologic management","volume":"5","author":"Jansson LM","year":"2009","unstructured":"Jansson LM, Velez M, Harrow C. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag. 2009, 5:47-55.","journal-title":"J Opioid Manag"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100179","article-title":"Buprenorphine-naloxone use in pregnancy: a\u00a0systematic review and metaanalysis","volume":"2","author":"Link HM","year":"2020","unstructured":"Link HM, Jones H, Miller L, Kaltenbach K, Seligman N. Buprenorphine-naloxone use in pregnancy: a\u00a0systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2020, 2:100179. 10.1016\/j.ajogmf.2020.100179","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones HE","year":"2010","unstructured":"Jones HE, Kaltenbach K, Heil SH, et al.. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010, 363:2320-31. 10.1056\/NEJMoa1005359","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2016.1146649","article-title":"Factors associated with buprenorphine versus methadone use in pregnancy","volume":"37","author":"Krans EE","year":"2016","unstructured":"Krans EE, Bogen D, Richardson G, Park SY, Dunn SL, Day N. Factors associated with buprenorphine versus methadone use in pregnancy. Subst Abus. 2016, 37:550-7. 10.1080\/08897077.2016.1146649","journal-title":"Subst Abus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99940-prenatal-buprenorphinenaloxone-or-methadone-use-on-neonatal-outcomes-in-michigan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:13Z","timestamp":1707507553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99940-prenatal-buprenorphinenaloxone-or-methadone-use-on-neonatal-outcomes-in-michigan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.27790","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,8]]}}}